CRGX Key Statistics, Chart & Performance
The current stock price of CRGX is 4.47 USD. In the past month the price decreased by -1.11%. In the past year, price decreased by -75.1%.
CRGX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 24.18 | 403.83B | ||
| AMGN | AMGEN INC | 14.97 | 176.25B | ||
| GILD | GILEAD SCIENCES INC | 14.99 | 152.28B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 26.12 | 115.03B | ||
| REGN | REGENERON PHARMACEUTICALS | 17.15 | 81.12B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 779.71 | 52.53B | ||
| INSM | INSMED INC | N/A | 37.12B | ||
| NTRA | NATERA INC | N/A | 31.62B | ||
| BIIB | BIOGEN INC | 10.51 | 25.82B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.46 | 20.98B | ||
| INCY | INCYTE CORP | 15.38 | 19.39B | ||
| EXAS | EXACT SCIENCES CORP | N/A | 19.27B |
Related stock screener links
About CRGX
Company Profile
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
Company Info
CARGO THERAPEUTICS INC
835 Industrial Road, Suite 400
San Carlos CALIFORNIA US
Employees: 167
Phone: 16504998950
CARGO THERAPEUTICS INC / CRGX FAQ
What does CARGO THERAPEUTICS INC do?
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
What is the stock price of CARGO THERAPEUTICS INC today?
The current stock price of CRGX is 4.47 USD. The price decreased by -1.54% in the last trading session.
What is the dividend status of CARGO THERAPEUTICS INC?
CRGX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CRGX stock?
CRGX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What sector and industry does CARGO THERAPEUTICS INC belong to?
CARGO THERAPEUTICS INC (CRGX) operates in the Health Care sector and the Biotechnology industry.
What is the Price/Earnings (PE) ratio of CARGO THERAPEUTICS INC (CRGX)?
CARGO THERAPEUTICS INC (CRGX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.66).
Can you provide the upcoming earnings date for CARGO THERAPEUTICS INC?
CARGO THERAPEUTICS INC (CRGX) will report earnings on 2025-11-10.
CRGX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CRGX. When comparing the yearly performance of all stocks, CRGX is a bad performer in the overall market: 93.99% of all stocks are doing better.
CRGX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CRGX. CRGX has a great financial health rating, but its profitability evaluates not so good.
CRGX Financial Highlights
Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -3.66. The EPS increased by 92.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -85.76% | ||
| ROE | -93.3% | ||
| Debt/Equity | 0 |
CRGX Forecast & Estimates
11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47.